304 related articles for article (PubMed ID: 32237932)
21. Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program.
Kanık Yüksek S; Tezer H; Gülhan B; Özkaya Parlakay A; Güldemir D; Coskun-Ari FF; Bedir Demirdağ T; Kara Uzun A; Kızılgün M; Solmaz S; Kılıç S; Yalınay Çırak M; Baran Aksakal FN
J Infect Public Health; 2020 Feb; 13(2):266-274. PubMed ID: 31818710
[TBL] [Abstract][Full Text] [Related]
22. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.
Gounder PP; Bruce MG; Bruden DJ; Singleton RJ; Rudolph K; Hurlburt DA; Hennessy TW; Wenger J
J Infect Dis; 2014 Apr; 209(8):1251-8. PubMed ID: 24273178
[TBL] [Abstract][Full Text] [Related]
23. Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.
Roca A; Bojang A; Bottomley C; Gladstone RA; Adetifa JU; Egere U; Burr S; Antonio M; Bentley S; Kampmann B;
Vaccine; 2015 Dec; 33(51):7144-7151. PubMed ID: 26592141
[TBL] [Abstract][Full Text] [Related]
24. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
Heinsbroek E; Tafatatha T; Phiri A; Swarthout TD; Alaerts M; Crampin AC; Chisambo C; Mwiba O; Read JM; French N
Vaccine; 2018 Nov; 36(48):7369-7376. PubMed ID: 30352744
[TBL] [Abstract][Full Text] [Related]
25. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
26. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.
Weil-Olivier C; van der Linden M; de Schutter I; Dagan R; Mantovani L
BMC Infect Dis; 2012 Sep; 12():207. PubMed ID: 22954038
[TBL] [Abstract][Full Text] [Related]
27. Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials.
Nunes MC; Moreira M; Koen A; van Niekerk N; Jose L; Cutland CL; François N; Schoonbroodt S; Ruiz-Guiñazú J; Yarzabal JP; Borys D; Schuerman L; Madhi SA
Expert Rev Vaccines; 2020 Dec; 19(12):1177-1189. PubMed ID: 33245004
[No Abstract] [Full Text] [Related]
28. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
[TBL] [Abstract][Full Text] [Related]
29. Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.
Principi N; Terranova L; Zampiero A; Montinaro V; Ierardi V; Peves Rios W; Pelucchi C; Esposito S
Pediatr Infect Dis J; 2015 Apr; 34(4):426-32. PubMed ID: 25760567
[TBL] [Abstract][Full Text] [Related]
30. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
[TBL] [Abstract][Full Text] [Related]
31. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
32. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
Dunn MG; Lessa FC; Sánchez J; Cordero R; Feris-Iglesias J; Cedano D; Carvalho MDG; Fernández J; Feemster KA
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S237-S247. PubMed ID: 34469551
[TBL] [Abstract][Full Text] [Related]
33. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
[TBL] [Abstract][Full Text] [Related]
34. PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
Vaccine; 2017 Feb; 35(6):945-950. PubMed ID: 28087146
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine.
Olwagen CP; Adrian PV; Madhi SA
Vaccine; 2020 Feb; 38(7):1762-1769. PubMed ID: 31874779
[TBL] [Abstract][Full Text] [Related]
36. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
Kaur R; Casey JR; Pichichero ME
Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
Allemann A; Frey PM; Brugger SD; Hilty M
Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
Southern J; Andrews N; Sandu P; Sheppard CL; Waight PA; Fry NK; Van Hoek AJ; Miller E
PLoS One; 2018; 13(5):e0195799. PubMed ID: 29799839
[TBL] [Abstract][Full Text] [Related]
39. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
[TBL] [Abstract][Full Text] [Related]
40. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.
Wroe PC; Lee GM; Finkelstein JA; Pelton SI; Hanage WP; Lipsitch M; Stevenson AE; Rifas-Shiman SL; Kleinman K; Dutta-Linn MM; Hinrichsen VL; Lakoma M; Huang SS
Pediatr Infect Dis J; 2012 Mar; 31(3):249-54. PubMed ID: 22173142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
